Daniel K Spiegelman Myriad Genetics Inc (MYGN) insider trading activity

Daniel K Spiegelman is Director of MYRIAD GENETICS INC. Currently has a direct ownership of 32,917 shares of MYGN, which is worth approximately $937,146. The most recent transaction as insider was on Jun 04, 2024, when has been sold 3,788 shares (Common Stock) at a price of $22.05 per share, resulting in proceeds of $83,525. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.9K

0% 3M change

18.71% 12M change

Total Value Held $937,146

DANIEL K SPIEGELMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 04 2024	SELL Open market or private sale	$83,525 $22.05 p/Share	3,788 Reduced 10.32%	32,917 Common Stock
Jun 03 2024	SELL Open market or private sale	$83,487 $22.04 p/Share	3,788 Reduced 9.35%	36,705 Common Stock
Jun 02 2023	SELL Open market or private sale	$198,760 $23.01 p/Share	8,638 Reduced 17.58%	40,493 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	-	15,151 Added 23.57%	49,131 Common Stock
Jun 06 2022	SELL Open market or private sale	$123,662 $19.25 p/Share	6,424 Reduced 15.9%	33,980 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	17,275 Added 29.95%	40,404 Common Stock
Jun 17 2021	SELL Open market or private sale	$95,802 $30.52 p/Share	3,139 Reduced 11.95%	23,129 Common Stock
Jun 03 2021	BUY Grant, award, or other acquisition	-	12,848 Added 32.85%	26,268 Common Stock
May 28 2021	SELL Open market or private sale	$207,047 $28.99 p/Share	7,142 Reduced 34.73%	13,420 Common Stock
May 27 2021	SELL Sale (or disposition) back to the issuer	-	15,889 Reduced 43.59%	20,562 Common Stock
Dec 04 2020	BUY Grant, award, or other acquisition	-	15,889 Added 30.36%	36,451 Common Stock

Also insider at

SPRB

SPRUCE BIOSCIENCES, INC. Healthcare

VTVT

vTv Therapeutics Inc. Healthcare

Director

DKS